[4647] in Athena User Interface
Huge market mover about to happen
daemon@ATHENA.MIT.EDU (ftqrfbcij)
Wed Nov 2 22:48:06 2005
message-id: <007a01c5e029$5f31d730$43f0a723@qmaqwc>
From: "ftqrfbcij" <ftqrfbcij@cityhot.com>
To: <atula@mit.edu>
Date: Wed, 02 Nov 2005 22:47:54 -0500
MIME-Version: 1.0
Content-Type: multipart/alternative;
boundary="----=_NextPart_000_0077_01C5DFFF.765BCF30"
This is a multi-part message in MIME format.
------=_NextPart_000_0077_01C5DFFF.765BCF30
Content-Type: text/plain;
charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
Best sto ck to finish out 2005 - read the story and you will se e for yourself.
Get WWBP First Thing Thursday, This Is Going To Exp lode!!!
Looking for a co mpany with some good news? Here's one!
Date: 2 Nov 2005
Company: Worldwide Biotech & Pharmaceutical Group
Stock: WWBP . OB
Current Price: $1.40
Up 15 cents in the last 5 days
About Worldwide Biotech & Pharmaceutical (Group) Co., Ltd.
Worldwide Biotech & Pharmaceutical Company ("WWBP") is a hi-tech
biotech company with top-ranking pharmaceutical R&D abilities,
Good Manufacturing Practices (GMP) licensed manufacturing facilities
and a well-established marketing network in China and Southeast Asia.
The product range of WWBP covers Hepatitis C Virus (HCV) products,
diagnostic medicines and Over-The-Counter (OTC) drugs.
WWBP currently possesses of 35,940 square meters of land
and 5,359 square meters of GMP standard facilities.
With strong pharmaceutical R&D abilities especially in the HCV field,
WWBP has been known as the first biotech company in the world
to hold the technology of culturing intact HCV in vitro by cell culture.
Its principle project ''the Intact Hepatitis C Virus (HCV) and Method
for Culturing HCV in Vitro by Cell Culture'' was awarded
with a Chinese patent by the China Patent Bureau and the prestigious
China Patent Golden Medal by the World Intellectual Property Organization
and China Patent Bureau. The medal is the only one issued for achievement
in the biomedical sciences during the past 10 years.
WWBP has achieved a GMP production scale level of 10,000 ml
for concentrated HCV material and 10 grams HCV antigen per month,
which is expected to bring WWBP considerable gross sale revenue
each year and greatly strengthen the company's R&D on anti-HCV drug screen
and HCV human vaccine. WWBP has successfully reached two merger agreements
with pharmaceutical companies in China, all of which have scalable production
and well-established sales network and the acquiring is expected
to be finished before the end of August 2005. The acquisitions
will strengthen WWBP's R&D abilities and production scale,
as well as extend its marketing network throughout China
and Southeast Asia. WWBP has been working closely
with pharmaceutical research institutes, and has established connections
with both central & local governments.
When this Stoc k moves... WATCH OUT! ...
This is your chance to get in while it is still low.
WWBP is a high growth issue and should be purchased by stock tra ders
and those that can afford to make quick money
on these fast moving issues. This is your chance to get your hands
on one of these fast moving stocks and take short term prof1ts.
This s tock could reach record highs in the near future.
We feel this is a "St ock Ale rt" and you should have this on your Radar
------=_NextPart_000_0077_01C5DFFF.765BCF30
Content-Type: text/html;
charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD>
<META http-equiv=Content-Type content="text/html; charset=iso-8859-1">
<META content="MSHTML 6.00.2800.1522" name=GENERATOR>
<STYLE></STYLE>
</HEAD>
<BODY bgColor=#ffffff>
<DIV><FONT face=Arial size=2>Best sto ck to finish out 2005 - read the story and
you will se e for yourself. <BR>Get WWBP First Thing Thursday, This Is Going To
Exp lode!!! <BR>Looking for a co mpany with some good news? Here's one!
<BR>Date: 2 Nov 2005 <BR>Company: Worldwide Biotech &
Pharmaceutical Group <BR>Stock: WWBP . OB <BR>Current Price: $1.40 </FONT></DIV>
<DIV><FONT face=Arial size=2>Up 15 cents in the last 5 days</FONT></DIV>
<DIV> </DIV>
<DIV><FONT face=Arial size=2>About Worldwide Biotech & Pharmaceutical
(Group) Co., Ltd. </FONT></DIV>
<DIV> </DIV>
<DIV><FONT face=Arial size=2>Worldwide Biotech & Pharmaceutical Company
("WWBP") is a hi-tech <BR>biotech company with top-ranking pharmaceutical
R&D abilities, <BR>Good Manufacturing Practices (GMP) licensed manufacturing
facilities <BR>and a well-established marketing network in China and Southeast
Asia. <BR>The product range of WWBP covers Hepatitis C Virus (HCV) products,
<BR>diagnostic medicines and Over-The-Counter (OTC) drugs. <BR>WWBP currently
possesses of 35,940 square meters of land <BR>and 5,359 square meters of GMP
standard facilities. <BR>With strong pharmaceutical R&D abilities especially
in the HCV field, <BR>WWBP has been known as the first biotech company in the
world <BR>to hold the technology of culturing intact HCV in vitro by cell
culture. <BR>Its principle project ''the Intact Hepatitis C Virus (HCV) and
Method <BR>for Culturing HCV in Vitro by Cell Culture'' was awarded <BR>with a
Chinese patent by the China Patent Bureau and the prestigious <BR>China Patent
Golden Medal by the World Intellectual Property Organization <BR>and China
Patent Bureau. The medal is the only one issued for achievement <BR>in the
biomedical sciences during the past 10 years. <BR>WWBP has achieved a GMP
production scale level of 10,000 ml <BR>for concentrated HCV material and 10
grams HCV antigen per month, <BR>which is expected to bring WWBP considerable
gross sale revenue <BR>each year and greatly strengthen the company's R&D on
anti-HCV drug screen <BR>and HCV human vaccine. WWBP has successfully reached
two merger agreements <BR>with pharmaceutical companies in China, all of which
have scalable production <BR>and well-established sales network and the
acquiring is expected <BR>to be finished before the end of August 2005. The
acquisitions <BR>will strengthen WWBP's R&D abilities and production scale,
<BR>as well as extend its marketing network throughout China <BR>and Southeast
Asia. WWBP has been working closely <BR>with pharmaceutical research institutes,
and has established connections <BR>with both central & local governments.
</FONT></DIV>
<DIV> </DIV>
<DIV><FONT face=Arial size=2>When this Stoc k moves... WATCH OUT! .... <BR>This
is your chance to get in while it is still low. <BR>WWBP is a high growth issue
and should be purchased by stock tra ders <BR>and those that can afford to make
quick money <BR>on these fast moving issues. This is your chance to get your
hands <BR>on one of these fast moving stocks and take short term prof1ts.
<BR>This s tock could reach record highs in the near future. <BR>We feel this is
a "St ock Ale rt" and you should have this on your Radar
<BR></FONT></DIV></BODY></HTML>
------=_NextPart_000_0077_01C5DFFF.765BCF30--
